🧫

Analysis of TP53-TP63/ΔNP63-EFNB1-EPHB4 axis in cancer progression

experiment Created: 2026-04-10 14:38:54 By: experiment_extractor Quality: 75% ✓ SciDEX ID: experiment-exp-291a1cad-3f58-40eb-95c1-0
🧫 Experiment Protocol Neuropathology
🧫 View Full Experiment Page →
Related Entities
TP53, TP63, EFNB1, EPHB4
Metadata
experiment_typeneuropathology
protocolhistopathological analysis and molecular characterization of cancer progression stages
expected_outcomesdemonstration of mechanistic link between TP53 mutation and aberrant epithelial interactions
success_criteriaevidence of TP53-TP63/ΔNP63 axis driving EFNB1-EPHB4 mediated EMT and proliferation
sample_sizeNone
statistical_methodsNone
p_valueNone
effect_sizeNone
extracted_at2026-04-10T07:38:54.252607
source_pmid38097539
_origin{'type': 'internal', 'url': None, 'tracked_at': '2026-04-10T14:38:54.322647'}
🌍 Provenance Graph 2 nodes, 1 edges

derives from (1)

Linked Artifacts (65)
derives_from📄Aberrant epithelial cell interaction promotes esophageal squ100%
mentions📖efnb180%
related📖efnb172%
mentions📖EPHB4 Gene70%
mentions📖TP53 Gene70%
mentions📖TP53 Protein (p53)70%
related📖EPHB4 Gene63%
related📖TP53 Gene63%
related📖TP53 Protein (p53)63%
mentions📖Cancer60%
mentions📖events60%
related📖Cancer54%
related📖events54%
mentions📖Ephrin/Eph Receptor Signaling Pathway in Neurodegeneration50%
mentions📖Tumor Necrosis Factor (TNF)50%
mentions📖Alpha-Synuclein Seed Kinetic Staging in Parkinson's Dis50%
mentions📖nct06365190-rtms-pd50%
mentions📖Astrocyte Senescence Pathway in Neurodegeneration50%
mentions📖Digital Therapeutics for Parkinson's Disease50%
mentions📖Cellular Senescence Hypothesis in Parkinson's Disease50%
mentions📖EphB Receptor Modulator Therapy44%
mentions📖dopaminergic-vta-pd44%
mentions📖Dorsal Raphe Serotonergic Neurons in Parkinson's Diseas44%
mentions📖Globus Pallidus Internus in Parkinsons Disease44%
mentions📖Melanocytes in Parkinson Disease44%
mentions📖Nigrostriatal Dopamine Terminals in Parkinson's Disease44%
mentions📖Dopaminergic Substantia Nigra Neurons in Parkinson's Di44%
mentions📖Synaptic Boutons44%
mentions📖Vulnerable Dopaminergic Neurons in Parkinson's Disease44%
mentions📖chemotherapy-resistance44%
mentions📖AB-1005 (REGENERATE-PD) GDNF Gene Therapy Trial44%
mentions📖Apocynin for Parkinson's Disease44%
mentions📖Bacillus Subtilis for Parkinson Disease (NCT06487975)44%
mentions📖biib122-luma-lrrk2-inhibitor-pd44%
mentions📖CT1-DAP001 iPS Cell-derived Dopaminergic Progenitors for Par44%
mentions📖Intranasal Insulin and Glutathione for PD (NOSE-PD)44%
mentions📖NCT05565443: MR-Guided Focused Ultrasound + GCase for Parkin44%
mentions📖nct05266417-nose-pd44%
mentions📖Autologous Stem Cell-Derived Dopaminergic Neurons for Parkin44%
mentions📖Dyadic Mindfulness for PD Carers (NCT06821230)44%
mentions📖Amino Acid Supplement in Parkinson's Disease (NCT06954644%
mentions📖Vibrotactile Stimulation Walking Speed PD Trial44%
mentions📖NouvNeu001 Cell Therapy for Parkinson's Disease44%
mentions📖PDE4 Inhibitor PD Trial44%
mentions📖Retigabine PD Trial44%
mentions📖Valacyclovir for HSV-1-Positive Parkinson's Disease44%
mentions📖NCT05881460: Vibrotactile Coordinated Reset for Parkinson&#x44%
mentions📖AMP-PD: Accelerating Medicines Partnership: Parkinson's44%
mentions📖Alpha-Synuclein SAA Kinetics Study — Biological Staging Back44%
mentions📖Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio44%
mentions📖Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation44%
mentions📖Combination Therapy Sequencing in Parkinson's Disease44%
mentions📖Selective Vulnerability of Dopaminergic Neurons — Mechanism 44%
mentions📖GLP-1 Agonist Responder Prediction Study — Precision Medicin44%
mentions📖Synaptic Mitochondrial Resilience Enhancement for Parkinson&44%
mentions📖MLCS Quantification Methods in Parkinson's Disease Rese44%
mentions📖[p53](/proteins/tp53) Pathway in [Parkinson](/diseases/parki44%
mentions📖Thioflavin-T Fluorescence Assay for Protein Aggregation44%
mentions📖AI-Powered Movement Analysis for Parkinson's Disease44%
mentions📖Digital Biomarker Platforms for Parkinson's Disease44%
mentions📖Wearable Sensors for Parkinson's Disease44%
mentions📖Adenosine A2A Receptor Antagonists44%
mentions📖CUE1 Non-Invasive Vibrotactile Device for Parkinson's D44%
mentions📖Sodium Oligomannate (GV-971) for Alzheimer's Disease44%
mentions📖Synaptic Plasticity Therapeutics for Parkinson's Diseas44%